Taxonomy, carcinogenic mechanisms, and advanced molecular diagnosis of Fusobacterium nucleatum in colorectal cancer: from bench to clinical practice - Top-Institutions - MDSpire

Taxonomy, carcinogenic mechanisms, and advanced molecular diagnosis of Fusobacterium nucleatum in colorectal cancer: from bench to clinical practice

  • By

  • Bin Li

  • Yifei Dong

  • Yifei Dai

  • Mengpei Zhang

  • Zhenwei Zou

  • Hai Yang

  • June 29, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Oncology

  • #2

    University of Melbourne
    University of Melbourne

    Melbourne, VIC

    Key Differentiators

    • Oncology

  • #3

    Peter MacCallum Cancer Centre
    Peter MacCallum Cancer Centre

    Melbourne, VIC

    Key Differentiators

    • Oncology

  • #4

    Leiden University Medical Center
    Leiden University Medical Center

    Leiden, ZH

    Key Differentiators

    • Oncology

  • #5

    Institute of Intelligent Medical Research
    Institute of Intelligent Medical Research

    N/A, N/A

    Key Differentiators

    • Oncology

Original Source(s)

Taxonomy, carcinogenic mechanisms, and advanced molecular diagnosis of Fusobacterium nucleatum in colorectal cancer: from bench to clinical practice

  • by Bin Li, Yifei Dong, Yifei Dai, Mengpei Zhang, Zhenwei Zou, Hai Yang

  • June 29, 2026

Related Content

A study on risk prediction of decline in self-care ability one month after discharge in postoperative colorectal cancer patients based on routine clinical indicators

Hemorrhage-coagulation immune phenotype is associated with CD163/HO-1-enriched heme-processing macrophage remodeling and predicts recurrence in colorectal cancer: a real-world retrospective cohort study

Comparative study of triple intravenous chemotherapy versus dual chemotherapy combined with hepatic arterial infusion in patients with liver metastases from colorectal cancer